NIH-funded research P01 program project

KSHV-driven tumor formation: how low-oxygen conditions push stem cells toward Kaposi’s sarcoma

Official title: Project 2: KSHV induces tumorigenesis by harnessing differentiation in hypoxia

Funded at University of Pennsylvania · NIH-11413534 · Data updated 2026-11-12

This project explores how low oxygen in tumors helps the Kaposi’s sarcoma virus hijack stem cells to form cancerous blood vessel–rich growths.

More Hypoxia research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2029
Funding year2026
Award (this year)$85,072
NIH project number5P01CA281867-04
Project IDNIH-11413534 on NIH RePORTER

Who could benefit from this research

Could help

Patients with AIDS-associated Kaposi’s sarcoma or related conditions may benefit from future therapies informed by this research.

Less likely to help

Individuals without KS or AIDS-associated cancers may not directly benefit from these findings.

What this research studies

Kaposi’s sarcoma is linked to infection with a virus (KSHV) and abnormal blood vessel growth in low-oxygen environments. The team will study how hypoxia activates HIF, a key regulator that can drive both normal development and cancer progression, in KS-related cells. They propose that KSHV may use the hypoxia response to push mesenchymal stem cells toward an endothelial-like state, fueling tumor formation. By examining these cellular changes in endothelial cells and MSCs, the research aims to uncover a mechanism of viral tumorigenesis that could reveal new targets for therapy. The work combines cellular models and molecular analyses to connect hypoxia, viral biology, and KS pathology.

Why it matters

Potential benefit: Understanding this mechanism could identify new strategies to prevent KS progression or develop targeted therapies for AIDS-associated cancers.

How similar studies have gone: Previous work indicates hypoxia and viral factors influence KS biology, and this project builds on those findings with a novel focus on MEndT and differentiation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Yuan, Yan — University of Pennsylvania
  • Study coordinator: Yuan, Yan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.